HemaSphere Journal (IF = 9.1)(@Hemasphere_EHA) 's Twitter Profile Photo

šŸ†•: Higher DNA damage response in leukemic stem cells (CD34+CD38-CD26+) isolated from Ph+ samples at diagnosis correlates with ā¬‡ļøprobability to maintain durable TFR upon treatment discontinuation. Read the publication šŸ‘‰bit.ly/3FmsTkv

account_circle
Global Marketing Services(@gmspakistan) 's Twitter Profile Photo

Cepheid offers a wide range of tests, from specialized oncology to routine testing for critical infectious diseases and healthcare-acquired infections. Our goal is to provide the solutions you need to make a positive impact.

Cepheid offers a wide range of tests, from specialized oncology to routine testing for critical infectious diseases and healthcare-acquired infections. Our goal is to provide the solutions you need to make a positive impact. 
#oncologydiagnostic #Chronicmyeloidleukemia
account_circle
Hematology Frontier(@Hematology_F) 's Twitter Profile Photo

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
mediamedic.co/olverembatinibā€¦

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial 
mediamedic.co/olverembatinibā€¦ 
#ChronicMyeloidLeukemia #Olverembatinib
account_circle
Ethan Hodge, Ed.S.šŸŽ—(@ethanehodge) 's Twitter Profile Photo

bit.ly/EthanhasCML Not exactly a ā€œtraditionalā€ holiday, but still one for somber observance. Thankfully there are brilliant scientists developing treatments that keep me alive and continuing to work toward a cure.

bit.ly/EthanhasCML Not exactly a ā€œtraditionalā€ holiday, but still one for somber observance.  Thankfully there are brilliant scientists developing treatments that keep me alive and continuing to work toward a cure. #chronicmyeloidleukemia 
#worldcancerday #cancelbloodcancer
account_circle
Hematology Frontier(@Hematology_F) 's Twitter Profile Photo

External Validation of Predictive Scoring Systems for Molecular Responses in Chronic Myeloid Leukemia Receiving Imatinib Therapy mediamedic.co/external-validā€¦

linkedin.com/pulse/externalā€¦

External Validation of Predictive Scoring Systems for Molecular Responses in Chronic Myeloid Leukemia Receiving Imatinib Therapy mediamedic.co/external-validā€¦ 

linkedin.com/pulse/externalā€¦
#ChronicMyeloidLeukemia
#CML #hematologyresearch #Leukemiajournal
account_circle
Hematology Frontier(@Hematology_F) 's Twitter Profile Photo

Imatinib compared with second-generation tyrosine kinase inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

mediamedic.co/imatinib-compaā€¦

linkedin.com/feed/update/urā€¦

Imatinib compared with second-generation tyrosine kinase inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase 

mediamedic.co/imatinib-compaā€¦ 

linkedin.com/feed/update/urā€¦

#AmericanJournalofHematology #ChronicMyeloidLeukemia #CML
account_circle
International CML Foundation (iCMLf)(@icmlf) 's Twitter Profile Photo

Still planning for EHA 2024? We've got your covered! We've just updated our guide with more information on the CML meeting schedule at the @
European Hematology Association congress. Check it out here: buff.ly/3UzGWKm

Still planning for EHA 2024? We've got your covered! We've just updated our guide with more information on the CML meeting schedule at the @ 
@EHA_Hematology congress. Check it out here: buff.ly/3UzGWKm

#EHA #CML #iCMLf #ChronicMyeloidLeukemia
account_circle
Veeda Clinical Research(@veedacr) 's Twitter Profile Photo

Discover our article on Challenges and Considerations for Conducting Phase II (CML)

Read more - bit.ly/3NNKXsv

To learn more about our Phase II Trial Solutions write to us at [email protected]

Discover our article on Challenges and Considerations for Conducting Phase II #ChronicMyeloidLeukemia (CML) #ClinicalTrials
 
Read more - bit.ly/3NNKXsv

To learn more about our Phase II Trial Solutions write to us at info@veedacr.com

#Veeda #Leukemia #Phase2Trials
account_circle
Kenyan Network of Cancer Organizations(@kenconetwork) 's Twitter Profile Photo

(CML) is a condition that demands our attention and compassion. Join us in casting a bright spotlight on CML at this year's World CML Day! The commemoration event will be held at The Nairobi Hospital on Saturday 23rd September from 10:00am.

#ChronicMyeloidLeukemia(CML) is a condition that demands our attention and compassion. Join us in casting a bright spotlight on CML at this year's World CML Day! The commemoration event will be held at @thenairobihosp on Saturday 23rd September from 10:00am. 
#WorldCMLDay
account_circle